Background--Stroke, caused by carotid plaque rupture, is a major cause of death in the United States. Whereas vulnerable human plaques have higher Fc receptor (FccR) expression than their stable counterparts, how FccR expression impacts plaque histology is unknown. We investigated the role of FccRIIb in carotid plaque development and stability in apolipoprotein (Apo)e À/À and Apoe À/À FccRIIb À/À double knockout (DKO) animals.
S
troke is the third leading cause of death in the United States. Each year, %600 000 people suffer a first stroke, with 1 death occurring every 4 minutes. 1 Most strokes are ischemic, resulting from rupture of vulnerable carotid plaques. Vulnerable plaques are characterized by accumulation of lipid laden foam cells, large areas of necrosis, and thin or absent fibrous caps. 2 Although atherosclerosis can be medically managed or surgically treated, the pathology responsible for formation of vulnerable versus stable plaques is still unclear. Studying the molecular mechanisms underlying plaque (in)stability requires the use of an appropriate model. Implantation of a constrictive device around the common carotid artery induces unstable plaques in apolipoprotein (Apo)e À/À and low-density lipoprotein receptor (LDLR)
À/À mice. [3] [4] [5] Constriction mimics the low, oscillatory flow that, in humans, predisposes sites to atherosclerosis. 6, 7 Murine carotid plaques are rich in macrophages (MØ), smooth muscle cells, and lipid 3 and have morphological features (eg, thin cap, necrotic core, reduced collagen area, and intraplaque hemorrhage) 5 characteristic of vulnerable human plaques. Additionally, the carotid artery is amenable to ultrasound biomicroscopy (UBM), allowing plaque development to be followed longitudinally. 7 Atherosclerosis is a chronic inflammatory disease, highlighting the involvement of the immune system in disease pathology. 8 The involvement of FccR in atherosclerosis is an active area of research. In humans, vulnerable carotid plaques have increased FccR expression and are more proinflamma-tory than their stable counterparts. 9 FccR bind immunoglobulin G (IgG) monomers or IgG-antigen immune complexes (IC). The activating receptors, FccRI (CD64) and III (CD16), are expressed in both humans and mice, whereas FccRIIa and IV are expressed in humans and mice, respectively. Activating FccR contain cytosolic immunoreceptor tyrosine-based activation motifs that recruit kinases and phospholipases to promote inflammatory responses. The inhibitory receptor, FccRIIb (CD32), is expressed on B cells and phagocytes. FccRIIb has a cytosolic immunoreceptor tyrosine-based inhibition motif that recruits phosphatases for dampening of responses.
In mouse models, we and others have shown that Fcc receptor (FccR) expression impacts plaque burden. 10, 11 Specifically, Apoe À/À mice lacking the FccR common c chain have less lipid accumulation in their descending aorta and aortic root than Apoe À/À animals. 10, 11 In an LDLR À/À model, aortic root lesions were decreased upon removal of CD16 (FccRIII). 12 Conversely, removal of the inhibitory FccRIIb on the Apoe À/À background increases the size of aortic root lesions. 13 Similarly, in an LDLR À/À chimeric mouse model, replacement of the bone marrow with that from FccRIIb À/À mice exacerbates lesion development in the descending aorta, compared to mice receiving control bone marrow. 14 How might FccR expression impact plaque stability? It has been shown that, as IC levels rise, with the associated increase in activating FccR occupancy, macrophages shift from a pro-to anti-inflammatory phenotype, as evidenced by reduced interleukin (IL)-12 and increased IL-10 production. 15 In vitro, macrophages are plastic, with their polarization state determined by the cytokine environment. 16 Of particular relevance to these studies are the conditions that polarize macrophages toward the anti-inflammatory, wound-healing end of the spectrum. These "alternatively activated" M2 macrophages secrete IL-10, but little IL-12, and are classified as M2a, M2b, or M2c, depending on the polarizing conditions. 17 IL-4 or IL-13 induce M2a macrophages, M2b are generated in response to IC and Toll-like receptor (TLR) engagement, and IL-10 induces the M2c subtype. Although models, plaque locations, and method vary, most studies agree that a T helper (Th)1/M1 response exacerbates atherosclerosis whereas Th2/M2 polarization is more protective. 18, 19 We generated a double knockout (DKO) mouse lacking both Apoe and FccRIIb to test the role of FccRIIb in plaque development and stability. The hypothesis was that loss of FccRIIb would exacerbate the inflammatory response, leading to greater atherosclerosis. We studied of the impact of FccRIIb expression on plaques in both the descending aorta (a standard mouse model of atherosclerosis) and carotid artery (a more translational and physiologically relevant site for stroke) and report that removal of FccRIIb dramatically skews the immune system toward the protective, anti-inflammatory end of the spectrum. Specifically, compared to their Apoe 
Cast Devices and Implantation
Conical casts (cone: 0.290.1 mm, 1.5 mm in length) were purchased from Promodling BV (The Hague, the Netherlands). Casts were sterilized under UV light (2 hours) and stored in 70% ethanol. Surgeries were performed within 24 hours of sterilization. Casts were placed around the right common carotid artery proximal to the bifurcation, as previously published. 4, 7 Briefly, the common carotid artery was exposed and separated from the vagus nerve. The constrictive device was placed around the artery; casts were tied with a single suture. Animals were housed individually postsurgery.
Ultrasound Biomicroscopy
UBM is a noninvasive technique that allows quantitation of plaque length, percent stenosis, and (as it is done on living animals as a repeated measure) calculation of the rate of plaque progression. Detailed descriptions of the methods, and validation by histological measurements, have been published. 7 Briefly, proper cast placement and altered blood flow were confirmed by UBM 2 weeks postsurgery, at which time baseline images were taken. Ultrasound was performed using the Vevo 770 high-resolution imaging system, as detailed previously. 7 Plaque length was measured using B-mode sagittal views. Plaques length was determined from the UBM images as previously described. 7 Length measurements were of a single continuous plaque, beginning at the proximal cast margin. Percent stenosis was calculated from transverse UBM images using NIH ImageJ software using the following formula:
where A L =the area of the lumen and A IEL =the area circumscribed by the internal elastic lamina. 7 The most stenotic region was reported.
Tissue Harvesting
Nine weeks postsurgery, animals were anesthetized, exsanguinated, and fixed in situ. Exsanguination involved nicking the left ventricle (LV) and the right atrium. A cannula attached to a peristaltic pump was inserted into the LV and the system flushed with cold PBS (1.5 mL/min, 10 minutes). Fixation was accomplished by perfusion with cold 4% formaldehyde/ PBS (1.5 mL/min, 10 minutes). The aortic arch and carotid arteries were removed and fixed for 4 hours in 4% paraformaldehyde/PBS. Tissues were transferred to 30% sucrose/ PBS overnight at 4°C. Tissue was thereafter transferred to a 1:1 solution of 30% sucrose/PBS/optimal cutting temperature (OCT; 1 hour) and embedded in OCT.
Histology, Immunohistochemistry, and Immunofluorescence
Plaques were sectioned (7 lm) from the proximal end of the cast for 0. 
Percent Stenosis
Percent stenosis was calculated with NIH ImageJ software using the following formula:
where A L =the area of the lumen and A IEL =the area circumscribed by the internal elastic lamina as reported. 7 The most stenotic region, representing the most severely compromised area, was reported for each genotype.
Plaque length
Excised carotid arteries were visualized using an Olympus SZ61 stereomicroscope and imaged using an Olympus DP20 camera. Plaque length was measured using digital microcalipers (Fisher Scientific), as previously described.
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CD68
Endogenous peroxidase was quenched with 0.3% H 2 O 2 (10 minutes, room temperature). Slides were rinsed with PBS and blocked with 0.1% Tween-20, 2% BSA, and 5% goat serum (1 hour). CD68 antibody (FA-11; Abcam, Cambridge, MA) was applied overnight at 4°C (1:100 in blocking buffer). Secondary antibody was goat anti-rat (60 minutes, room temperature; Vector Laboratories, Burlingame, CA). Antibody was visualized using Vector's ABC kit with diaminobenzadine (BD Biosciences, Franklin Lakes, NJ), followed by hematoxylin counterstain.
Arg-1 and iNOS
Slides were dried overnight and fixed in acetone (10 minutes, À20°C), then rehydrated with PBS (10 minutes) and blocked with 0.5% fish gelatin (G-7765; Sigma-Aldrich, St. Louis, MO), 1% BSA, and 0.3% Triton X-100 (blocking buffer, 1 hour, room temperature). Sections were treated with antibodies to Arg-1 (GTX109242 
Picrosirius Red
Frozen sections were fixed in 70% ethanol (3 minutes) and washed with distilled water (3 minutes). Sections were stained with 0.1% Sirius Red/Sigma Direct Red 80 in saturated aqueous solution of picric acid for 1 hour. Sections were washed twice with 0.5% acetic acid (5 minutes), dehydrated with 100% ethanol, cleared with xylene, and mounted with Cytoseal XYL (Richard-Allan Scientific, Kalamazoo, MI). Percent Picrosirius Red-positive area was quantified using NIH ImageJ as described above for ORO.
% Picrosirius red area ¼ ðPicrosirius red-positive area/ totalplaqueareaÞ Â 100
Trichrome
Slides were fixed in 70% ethanol (2 minutes), rinsed, and incubated in Bouin's fluid (56°C, 1 hour). Sections were sequentially rinsed, stained with Weigert's hematoxylin, rinsed, stained with Biebruch scarlet-acid fuschin, rinsed again, incubated with phosphomolybdic/phosphotungstic acid, and then stained with Aniline Blue (10 minutes each step). Sections were rinsed, incubated in 1% acetic acid (3 minutes), then dehydrated and mounted with Cytoseal XYL (Richard-Allan Scientific).
Plaque vulnerability index
Stability of plaques was assessed by a clinical pathologist, blinded to the genotype of each animal. Three to six sections from each plaque, spaced at least 0.1 mm apart, were analyzed. Plaque stability for each animal was scored using the most vulnerable sections from each plaque.
Necrosis
Necrotic areas were defined from trichrome-stained sections as deep acellular, debris-containing areas within a plaque based on the work of Seiman et al.
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% Necrotic area ¼ ðnecrotic area/total plaque areaÞ Â 100
Plasma Assays
Cholesterol and triglyceride
Cholesterol and triglyceride (TG) levels were determined using cholesterol and TG assay kits (Cayman Chemical Company, Ann Arbor, MI), according to the manufacturer's instructions.
Immunoglobulin
Plasma IgG, IgM, IgG1, and IgG2a levels were determined using immunoperoxidase-based ELISAs (Immunology Consultants Laboratory, Portland, OR), according to the manufacturer's instructions.
Oxidized LDL
Plasma oxidized LDL (oxLDL) levels were determined by ELISA for oxLDL (Uscn Life Science Inc., Wuhan, China), according to the manufacturer's instructions.
oxLDL-IC
ELISA plates were coated (2 hours, room temperature) and incubated overnight (4°C) with anti-apolipoprotein B antibody (polyclonal; Abcam) diluted 1:750 in PBS. Subsequently, plates were washed with 0.05% Tween-20/PBS and blocked 3 times (10 minutes) with SuperBlock Blocking Buffer/TBS (Thermo Scientific, Waltham, MA). Plasma was diluted 1:500 in diluent buffer (0.1% Tween-20, 10% SuperBlock/TBS) and applied (2 hours, room temperature). Incubation continued overnight at 4°C. Plates were then washed 3 times. Next, a 1:500 dilution of horse anti-mouse IgG (Vector Labs) was added (2 hours, room temperature). The plate was again incubated with streptavidin-HRP (1:1000; BD Biosciences) for 1 hour (room temperature). The plate was washed 3 times, a 1:2 solution of BD Opt EIA TMB Substrate Reagent Set (BD Biosciences) was added, and the reaction was stopped with H 3 PO 4 after 2 minutes.
Cytokines
Cytokines were measured using Bio-Plex Custom Luminex â Arrays according to the manufacturer's instructions.
RNA Extraction and Quantitative PCR
Plaques and the associated artery were removed from exsanguinated animals and lysed in Tri-reagent (Molecular Research Center, Cincinnati, OH). Right cervical lymph nodes were homogenized and seeded at 1910 6 cells/ 0.75 cm 2 . Cells were treated with phorbol 12-myristate 13-acetate (PMA; 20 ng/mL) and ionomyocin (1 lg/mL) for 4 hours (37°C). RNA was isolated from Tri-reagent lysed tissues according to the manufacturer's instructions. cDNA was prepared from RNA using iScript (Bio-Rad, Hercules, CA). Qunatitative PCR (qPCR) primers were designed using Primer Express 3.0 (Applied Biosystems, Foster City, CA) to amplify unique sequences (as determined by BLAST analysis) of 100 to 200 bp that crossed an intron. cDNA was amplified using PerfeCta SYBR Green Fast Mix (Quanta BioSciences, Inc., Gaithersburg, MD) with a
Step One Plus Real-Time PCR System (Applied Bioscience). Relative expression of each gene was calculated using the DDCt method. Relative abundance of mRNA was normalized to b-actin and calculated as: 2^À(C t geneÀC t b-actin), where C t represents the threshold cycle for each transcript. Primers are listed in Table 1 . 
Flow Cytometry
Results
Model for Induction of Carotid Plaques
Placement of a shear stress-modifying cast around the common carotid artery promotes plaque formation proximal to the cast. 3, 5, 7 UBM pulse-wave Doppler is a noninvasive tool to monitor plaque length and stenosis. 7 Using carotid constriction and UBM in 15-to 26-week-old mice, we determined the effect of FccRIIb expression on the development and histology of carotid plaques ( Figure 1A ).
Loss of FccRIIb Reduces Carotid Stenosis
Plaque length and percent stenosis were followed longitudinally using UBM ( Figure 1A ). The rate of plaque development, calculated as change in plaque length with time, was not significantly different ( Figure 1B ). In contrast, stenosis, a clinical metric of plaque risk, was significantly less in DKO plaques ( Figure 1C ). UBM parameters were validated by direct measurements of plaque length and stenosis (Figure 1D ) from 9-week postsurgery tissue. With respect to percent stenosis, values measured by UBM were consistently lower than those obtained postmortem. The likely explanation is that, in live animals, blood pressure keeps the artery lumen more open. The lower stenosis (with similar plaque length) suggests that DKO mice have less carotid plaque. To determine whether these differences were specific to the carotid artery, we quantified plaque area in the descending aorta using ORO lipid staining. 14, 21 Based on this standard measure of atherosclerosis, DKO aortas had less significantly less ORO staining, compared to their Apoe À/À counterparts ( Figure 2 ).
Similar results between the carotid and descending aortas suggest that the lower carotid plaque burden in DKO animals is not site specific.
FccR Expression Affects Plaque Histology
DKO plaques resemble stable human carotid plaques
Guided by American Heart Association criteria, 22 trichromestained carotid plaques from Apoe À/À and DKO animals ( Figure 3A) were scored for stability. The slides were arbitrarily numbered to obscure the genotype and scored by a pathologist experienced in grading human plaques. (Note: Given that this work assesses mouse plaques for features characteristic of human plaques, we chose the terms "high risk" and "stable," acknowledging that high risk implies likely to rupture, rare in mice. 5 )
Multiple sections (3 to 10, depending on plaque length) corresponding to different plaque regions spaced 0.1 mm apart were scored on a 6-point scale, with "1" being no plaque and "6" being lipid rich with little or no fibrosis ( Figure 3B ). Plaques with subendothelial lipid and buried fibrosis were given higher scores ("5"), whereas morefibrotic plaques with buried lipid scored lower ("3"). The scores for each region were averaged and plotted. DKO plaques scored significantly lower (P<0.01) than Apoe À/À , indicative of relative stability ( Figure 3B ). The differences are still significant if animals with no plaque are excluded from the analysis (P<0.05). Given the significant differences in scores, with DKO plaques scored more stable than Apoe À/À , histological analyses were done to quantify established indicators of human plaque vulnerability (necrosis, retained lipid, and collagen).
Necrotic area is smaller in DKO plaques
Necrosis is a feature of advanced human plaques and arises from the defective clearance of apoptotic cells 23 (efferocytosis). The combination of a necrotic core and thin/absent cap increases the risk of plaque rupture and stroke in humans. 23 Because there is no direct stain for necrosis, it was inferred from trichrome-stained sections. Intraplaque areas (as reported by Seimon et al. 20 ) ( † in Figure 3A) were scored as necrotic. By this criterion, necrosis was significantly higher in Apoe À/À ( Figure 3A and 3C).
DKO plaques have significantly less retained lipid
Plasma levels of cholesterol and TG trended higher in DKO mice, but were not significantly different (Apoe À/À : 1345AE157 and 106AE16; DKO: 1703AE362 and 175AE50, respectively, meanAESEM, n=7 to 9). However, quantitation of ORO-positive area revealed significantly less overall lipid in DKO plaques ( Figure 4A ). Moreover, average lipid inclusion size was significantly smaller in DKO plaques ( Figure 4A ). Differences in retained lipid could result from alterations in uptake. Thus, we quantified scavenger receptor class A (SR-A), CD36, and lectin-like oxidized low-density lipoprotein receptor 1 (Lox-1) receptor expression in plaques. SR-A and Lox-1 message levels were similar ( Figure 4B ); CD36 levels were elevated in DKO plaques. Paradoxically, up-regulation of CD36 would be expected to increase lipid retention and thus cannot explain the significantly smaller lipid inclusions present in DKO plaques. It is possible that uptake through different receptors or alterations in cholesterol efflux vary between the genotypes. ). Data were analyzed by independent sample t test. **P<0.01.
DKO plaques have fibrous caps
Quantification of Picrosirius Red staining (as a percentage of plaque area) established that the amount of collagen in Apoe À/À and DKO plaques was similar ( Figure 5A ). However, a comparison of the matrix stained either with trichrome (blue in Figure 3A ) or Picrosirius Red ( Figure 5A ) revealed difference in its distribution. Specifically, matrix was localized beneath foam cells in the majority of Apoe À/À plaques.
Quantitatively, 58% of Apoe À/À and 36% of DKO plaques (11 of 19 and 5 of 13, respectively; Figure 3B ) had buried caps (stage 5) or little/no fibrosis (stage 6). In contrast, collagen was concentrated in thick caps ( Figure 5A and 5B) and/or throughout the plaque ( Figures 3A and 5 ) in the majority (8 of 13; 62%) of DKO plaques. In humans, superficial collagen protects the fatty/necrotic core, favoring stabilization. In contrast, collagen buried beneath ORO + areas exposes the foam cells to the vessel lumen and increases vulnerability. mice had no plaque ( Figure 2B ) and 2 of 18 (11%) had plaques with no CD68 + cells. The remaining 11 contained CD68 + cells that were, for the most part, embedded in matrix ( Figure 5B ). qRT-PCR for CD68 in plaques was similar ( Figure 5B ). Given that its expression was normalized to b-actin, the results suggest that the percentage of macrophages is similar regardless of plaque size and is consistent with what has been reported for human carotid plaques. 9 Thus, differences in the percentage of MØ cannot explain the fibrotic nature of the DKO plaques.
Histologically, large macrophages (MØ) with expanded ORO-positive cytoplasm (foam cells) and smaller MØ have been associated with pro-(M1) and anti-inflammatory (M2, M hem , and M ox ) polarization, respectively. 25, 26 M1 polarized MØ express iNOS, whereas M2 synthesize Arg-1 (reviewed previously 27 ). If the MØ in Apoe À/À plaques are M1 polarized, they should preferentially express iNOS. Conversely, DKO MØ should be enriched for Arg-1. Three sections of each plaque were stained for iNOS or Arg-1. The slides were given arbitrary numbers and scored by a lab mate blinded to both the genotype and identity of the stained protein. When the code was broken and the averages calculated, Apoe À/À plaques had significantly higher iNOS and lower Arg-1 ( Figure 6A ), suggesting M1 and M2 polarization of Apoe À/À and DKO plaque MØ, respectively. Additionally, expression of IL-10, transforming growth factor beta (TGF-b) and TNF-a within the plaques was quantified ( Figure 6B ). Although IL-10 (anti-inflammatory) trended higher and TNF-a (proinflammatory) trended lower in DKO plaques, the differences, although not significant, were similar to those in the blood (see below) and are consistent with an overall M2/anti-inflammatory environment.
In summary, multiple histological measures provide evidence that DKO carotid plaques share features of stable human plaques and that removal of FccRIIb attenuates carotid plaque development. Immunostaining suggests that DKO plaques express M2 MØ, whereas those from Apoe À/À animals are more M1 polarized, providing a potential explanation for the differences in plaque histology. Because MØ polarization is a function of environment, we interrogated immune tissues for evidence of skewing.
DKO Blood Contains Markers of AntiInflammatory Skewing
There were no significant differences in the major circulating cell populations (Table 2) . We quantified cytokine levels as a readout of systemic immune polarization. Although there were no significant differences in IL-4 or interferon-gamma (IFN-c), IL-10 trended higher, and TNF-a, IL-1b, and IL-12 were significantly lower in DKO plasma (Figure 7) . The IL-10/IL-12 ratio, an indicator of inflammatory status, was significantly higher in DKO Analysis of flow cytometric data of peripheral blood of 26-week animals. Data are presented as meanAESEM percent of the total cell population. Data were analyzed by independent sample t test. No significant differences were found. Apo indicates apolipoprotein; DKO, double knockout. *Percent of CD3 + population. . For immune complex levels, the assay controls contained either no serum or serum from 26-week C57/BL6 mice on chow diet. The IC concentration was significantly higher in DKO, compared to Apoe ) and 10 (DKO) animals. Significance was determined by independent sample t test. *P<0.05; **P<0.01; **P<0.001. Apo indicates apolipoprotein; DKO, double knockout; IC, immune complexes; IgG, immunoglobulin G; oxLDL, oxidized low-density lipoprotein.
(CD16-1), or FccRIV (CD16-2) (Figure 10 ). Additionally, we examined FccR function by assessing IgG-mediated phagocytosis. Using our published protocol, 34 
Lymph Nodes of DKO Animals Suggest T reg Skewing
The interplay between the lymph nodes and tissues allowed us to interrogate the plaque environment by analyzing the cervical lymph nodes draining the casted artery. CD4 + cells, notably CD4 + Foxp3 + T regs , were a higher percentage of the total CD3 cell population in DKO animals ( Figure 11A and Table 3 ). CD4 + Foxp3 + T regs contribute to atheroprotection 35, 36 and are linked to plaque stability in humans. 37 In addition, the percentage of antigen-presenting cells, that is, background results in skewing the immune system in an anti-inflammatory M2 direction that is atheroprotective.
Conclusions
Apoe À/À IIb À/À DKO mice have reduced atherosclerosis and fibrous carotid plaques. Based on our studies 9 and those of others, 13, 14 we predicted that loss of FccRIIb would exacerbate atherosclerosis. Surprisingly, the results disproved the hypothesis, with initial evidence coming from longitudinal studies ( Figure 1 ). Reduced plaque burden is not site specific given that DKO mice have less plaque in the carotid arteries (Figure 1 ), the descending aorta (Figure 2) retention. Given that the scavenger receptors involved in lipid uptake were not significantly different ( Figure 4B ), it would suggest that FccRIIb expression may influence lipid efflux. The DKO animals provide a model for studying this process. How does loss of FccRIIb shift the immune polarization of DKO mice? In addition to myeloid cells, FccRIIb is expressed on B cells, where its engagement suppresses B-cell receptor signaling and regulates IgG production. 41 In its absence, IgG production continues unfettered, resulting in the elevation of both IgG and IC (Figure 8 ). Though mechanistic studies need to be done, we propose that elevated IgG, with IL-10 acting downstream, is driving the DKO plaque phenotype. Elevated IgG produces IC, which are significantly higher in DKO serum (Figure 8 ). IC, combined with TLR4 ligands (saturated fatty acids derived Although a minor component of IgG, their absolute concentration in DKO serum is likely elevated in proportion to the overall 2-fold increase in IgG levels ( Figure 8 ). Second, it has been reported that the constant fragment of IgG contains MHC-binding epitopes ("Tregitopes") that, when incubated with peripheral blood mononuclear cells (PBMCs), activate T regs and induce IL-10 expression. 45 The draining lymph nodes of DKO mice have elevated antigenpresenting cells (mDCs and MØ; Table 3 ) that could present Tregitopes (higher in DKOs as a result of IgG levels; Figure 8 ) to na€ ıve T cells, producing the T regs that are enriched in DKO lymph nodes ( Figure 11) Figure 6 ) and its up-regulation in DKO MØ treated with IC and LPS ( Figure 9 ).
Why Do These Results Differ From Other DKO Atherosclerosis Reports?
The results disproved our hypothesis and are in direct contrast to the literature. 13, 14 The differences may arise from the extent of backcrossing in the FccRIIb knockout mice used to generate the DKOs. Specifically, the FccRIIb À/À mice used to generate the Apoe À/À FccRIIb À/À DKO used in the published report 13 were strain 002848 (The Jackson Laboratory), a mixture of C57BL/6 and 129S. Single-nucleotide polymorphism analyses confirmed that the 002848 strain is %50% 129S, whereas the Taconic FccRIIb À/À strain #580 is greater than 95% C57BL/6 (see H. Ng et al, unpublished data). Thus, the genetic background of our mice is predominantly C57/BL6 ("congenic"), whereas that of the mice from the other group 13 are on a mixed background. "Mixed" versus congenic DKO mice produce diametrically opposite results, with the mixed background exhibiting proinflammatory skewing and the congenic mice (used in this study) being antiinflammatory. Notably, others have documented a similar FccRIIb congenic versus mixed disparity in a lupus model and determined that, similar to these atherosclerosis results, the mixed DKO are susceptible to lupus, whereas the congenic DKO are protected. 46 The reader is directed to our second article (H. Ng et al, unpublished data) for additional studies on reduced atherosclerosis in this DKO mouse. The 2 articles use different atherosclerotic sites, diets, and age, demonstrating that the protective environment is a general feature of high-fat-dietfed congenic FccRIIb/Apoe DKO mice. Additionally, whereas the focus of the present manuscript defines the histological differences in carotid plaques of Apoe À/À and DKO mice, the polarization of the macrophages in the plaques, and immune composition of the lymph nodes, the companion article (H. Ng et al, unpublished data) establishes that the protective environment of the DKO animals derives from the congenic background of the mice. In that article, the responses of macrophages from mixed and congenic background DKO mice were directly compared and shown to be pro-and antiinflammatory, respectively, with the protective phenotype a function of the congenic background. The results detailed herein advance our understanding of the mechanisms underlying the development of stable plaques. That the model has translational potential is apparent from studies reporting that humans that have elevated levels of IL-10 and T regs develop less-vulnerable plaques. running the Luminex â arrays, Danielle Califano for advising with flow cytometry, and Casey O'Connor for assisting with data collection.
